ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -2 مورد

Management of nonsevere (MVA >1.5 cm2) rheumatic mitral stenosis

Management of nonsevere (MVA >1.5 cm2) rheumatic mitral stenosis
All patients with rheumatic mitral stenosis should receive routine follow-up and medical management including drug therapy (eg, diuretic) for heart failure, management of atrial fibrillation, and anticoagulation as indicated.

LA: left atrial; MR: mitral regurgitation; MS: mitral stenosis; MVA: mitral valve area; PAWP: pulmonary artery wedge pressure; PMBC: percutaneous mitral balloon commissurotomy.

* PAWP is generally measured by pulmonary artery catheter. Mean mitral valve gradient is most commonly measured by Doppler echocardiography.

¶ The favorability of mitral valve morphology is based upon valvular and subvalvular features associated with successful PMBC (effective reduction of severity of MS without inducing/worsening MR). Refer to UpToDate content on scoring systems to assess the favorability of mitral valve morphology and other criteria for PMBC.
Graphic 139030 Version 2.0